Hallucinogen persisting perception disorder

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Hallucinogen persisting perception disorder
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Visual snow, afterimages, trailing, halos, macropsia, micropsia
Complications	N/A
Onset	After use of hallucinogens
Duration	Can be chronic
Types	N/A
Causes	Use of psychedelic drugs such as LSD, psilocybin, mescaline, MDMA
Risks	Previous use of hallucinogens
Diagnosis	Based on clinical history and symptoms
Differential diagnosis	Schizophrenia, migraine, epilepsy, anxiety disorder
Prevention	N/A
Treatment	Benzodiazepines, anticonvulsants, antipsychotics
Medication	N/A
Prognosis	Varies; some cases resolve, others persist
Frequency	Rare, exact prevalence unknown
Deaths	N/A

Hallucinogen Persisting Perception Disorder (HPPD) is a condition characterized by a continual presence of sensory disturbances, most commonly visual, that are reminiscent of those generated by the use of hallucinogenic substances. Individuals with HPPD experience these disturbances without recent use of hallucinogens. The disorder disrupts daily life for the affected individuals, making it difficult for them to perform routine tasks.

Symptoms

The primary symptom of HPPD is the persistent re-experiencing of visual phenomena that resemble those produced by the ingestion of hallucinogenic substances. These can include:

• Visual snow or static
• Afterimages or trailing images
• Halos around objects
• Geometric hallucinations
• Intensified colors
• Palinopsia (abnormal persistence or recurrence of images after the object is out of the field of vision)
• Micropsia and macropsia (objects appear smaller or larger than normal, respectively)

These symptoms can vary in intensity and may be exacerbated by stress, lack of sleep, or other stimuli.

Causes

The exact cause of HPPD is not fully understood, but it is believed to result from alterations in brain chemistry or structure following the use of hallucinogenic drugs. Substances commonly associated with HPPD include:

• Lysergic acid diethylamide (LSD)
• Psilocybin (magic mushrooms)
• Mescaline (peyote)
• MDMA (ecstasy)
• Cannabis (marijuana)

Diagnosis

Diagnosis of HPPD is primarily based on the patient's history and symptoms, as there are no specific tests for the disorder. It is important to differentiate HPPD from other conditions that may cause similar symptoms, such as migraines, epilepsy, or other neurological disorders.

Treatment

Treatment for HPPD is largely symptomatic and may include:

• Antipsychotic medications
• Benzodiazepines
• Antidepressants
• Counseling or psychotherapy

Lifestyle changes, such as reducing stress and avoiding substances that can trigger symptoms, are also recommended.

Prognosis

The prognosis for individuals with HPPD varies. Some individuals may experience a gradual improvement in symptoms over time, while others may have persistent symptoms that interfere with their quality of life.

Epidemiology

The prevalence of HPPD is not well-documented, but it is considered a rare disorder. It is most commonly reported among individuals with a history of frequent hallucinogen use.

History

The phenomenon now known as HPPD was first documented in the medical literature in the 1950s, with increased recognition following the widespread use of hallucinogens in the 1960s and 1970s.

See Also

• Psychedelic drug
• Visual perception
• Substance use disorder

   This article is a medical stub. You can help WikiMD by expanding it!